CN Stock MarketDetailed Quotes

600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.

Watchlist
  • 20.49
  • +0.25+1.24%
Market Closed Dec 12 15:00 CST
9.59BMarket Cap89.09P/E (TTM)

Vcanbio Cell & Gene Engineering Corp.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vcanbio Cell & Gene Engineering Corp.,Ltd. Q3 2024 Earnings Date

Currency：CNYOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
403.62M
--
-0.17%
EPS
--
0.11
--
--
Analyst Rating
Strong Buy

Dec 12, 2024

Vcanbio Cell & Gene Engineering Corp.,Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.867B--
--2024/FY-- / 1.737B--
--2023/FY1.590B / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.867B--
--2024/FY-- / 1.737B--
--2023/FY1.590B / ----
--------
--------

Unlock Free Earnings Estimates

Vcanbio Cell & Gene Engineering Corp.,Ltd. Earnings Reports

  • Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. Report for the third quarter of 2024

    Oct 29 12:00 ET

  • Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2024 Semi-Annual Report

    Aug 29 12:00 ET

  • Summary of the 2024 semi-annual report of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd.

    Aug 29 12:00 ET

  • Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2023 Annual Report

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme The Concept of in Vitro Diagnosis
    The Concept of in Vitro Diagnosis
    Intraday+1.25%
    Finance and Securities Lending
    Finance and Securities Lending
    Intraday+1.01%
    Assisted Reproduction
    Assisted Reproduction
    Intraday+1.01%